KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Enterprise Value (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Enterprise Value readings, the most recent being -$3.2 billion for Q1 2026.

  • On a quarterly basis, Enterprise Value rose 44.17% to -$3.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was -$3.2 billion, a 44.17% increase, with the full-year FY2025 number at -$10.1 billion, down 85.28% from a year prior.
  • Enterprise Value hit -$3.2 billion in Q1 2026 for Thermo Fisher Scientific, up from -$10.1 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$1.8 billion in Q3 2022 to a low of -$10.1 billion in Q4 2025.
  • Median Enterprise Value over the past 5 years was -$5.8 billion (2025), compared with a mean of -$5.4 billion.
  • Biggest five-year swings in Enterprise Value: surged 76.72% in 2022 and later tumbled 188.34% in 2024.
  • Thermo Fisher Scientific's Enterprise Value stood at -$8.4 billion in 2022, then rose by 5.3% to -$8.0 billion in 2023, then surged by 31.55% to -$5.4 billion in 2024, then crashed by 85.28% to -$10.1 billion in 2025, then soared by 67.83% to -$3.2 billion in 2026.
  • The last three reported values for Enterprise Value were -$3.2 billion (Q1 2026), -$10.1 billion (Q4 2025), and -$3.4 billion (Q3 2025) per Business Quant data.